JP Patent

JP6837469B2 — 疾病の薬理シャペロン治療に対する応答性を予測する方法

Assigned to アミカス セラピューティックス インコーポレイテッド · Expires 2021-03-03 · 5y expired

What this patent protects

Patent listed against migalastat-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP6837469B2
Jurisdiction
JP
Classification
—
Expires
2021-03-03
Drug substance claim
No
Drug product claim
No
Assignee
アミカス セラピューティックス インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.